English español

Repositorio de la Universidad de Oviedo. > Producción Bibliográfica de UniOvi: RECOPILA > Artículos >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10651/35609

Title: Clinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out
Author(s): Neumann, Hartmut P. H.
Erlic, Zoran
Boedeker, Carsten Christof
Rybicki, Lisa A.
Robledo, Mercedes
Sevilla García, María Agustina
Hermsen, Mario
Issue date: 2009
Publisher version: http://dx.doi.org/10.1158/0008-5472.CAN-08-4057
Citation: Cancer Research, 69(8), p. 3650-3656 (2009); doi:10.1158/0008-5472.CAN-08-4057
Format extent: p. 3650-3656
URI: http://hdl.handle.net/10651/35609
ISSN: 0008-5472
Sponsored: Grant 107995 (H.P.H. Neumann), the Deutsche Forschungsgemeinschaft (NE 571/5-3; H.P.H. Neumann), and the European Union (LSHC-CT-2005-518200; H.P.H. Neumann). C. Eng is the recipient of a Doris Duke Distinguished Clinical Scientist Award, and is the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic. C. Suarez is supported by a grant from the Fondo de Investigaciones Sanitarias (FIS; PI052071) and Red Tematica de Investigacio ́n Cooperativa en Ca ́ncer (RD06/0020/0034). M. Robledo is supported by a grant from FIS (PI042154) and Centro de Investigacio ́n Biome ́dica En Red de Enfermedades Raras.
Appears in Collections:Artículos

Files in This Item:

There are no files associated with this item.

Exportar a Mendeley

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Base de Datos de Autoridades Biblioteca Universitaria Consultas / Sugerencias